Gelteq (GELS) Receivables - Other (2023 - 2025)

Gelteq (GELS) recorded quarterly Receivables - Other of $250281.3 in Q2 2025, up 25.48% quarter-over-quarter from $199461.3 in Q4 2024, and up 165.0% on a YoY basis from $94446.8 in Q2 2024.

Gelteq (GELS) Receivables - Other (2023 - 2025) Analysis & Trends

Gelteq's Receivables - Other history runs 3 years deep, the most recent figure standing at $250281.3 for Q2 2025.

  • In Q2 2025, Receivables - Other rose 165.0% year-over-year to $250281.3; the TTM figure through Jun 2025 stood at $250281.3 (up 165.0% YoY), while the FY2025 annual figure was $250281.3, up 165.0% from the prior year.
  • Receivables - Other was $250281.3 for Q2 2025 at Gelteq, up from $199461.3 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $250281.3 in Q2 2025 to a low of $94446.8 in Q2 2024.
  • Historically, Receivables - Other has averaged $180001.6 across 3 years, with a median of $187639.1 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other plunged 46.28% in 2024, then jumped 165.0% in 2025.
  • A 3-year view of Receivables - Other shows it stood at $175816.9 in 2023, then advanced by 13.45% to $199461.3 in 2024, then advanced by 25.48% to $250281.3 in 2025.
  • The last three Receivables - Other figures came in at $250281.3 (Q2 2025), $199461.3 (Q4 2024), and $94446.8 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Gelteq 10.57 Mn 10.34 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 250,281.30
Jun 30, 2025 250,281.30
Dec 31, 2024 199,461.34
Dec 31, 2024 199,461.34
Jun 30, 2024 94,446.78
Jun 30, 2024 94,446.78
Jun 30, 2023 175,816.89
Jun 30, 2023 175,816.89